Global Vendor Neutral Archive (VNA) Market is Anticipated to Witness High Growth Owing to Upsurge in Demand for Efficient Medical Image Management

 

Global Vendor Neutral Archive (VNA) Market Trends

A vendor neutral archive (VNA) refers to a healthcare interoperability platform that manages medical imaging exams and integrates with multiple clinical systems. It helps in enhancing collaboration between medical practitioners and provides easy access to medical images through a centralized data store, thus allowing care providers to easily share and transfer patient information. It has gained significant traction due to growing hospital workflow complexities and need for an integrated approach for medical image storage, management and access across diverse clinical environments. VNA supports import and storage of both DICOM and non-DICOM files which includes images from various modalities like CT, MRI, PET scans, cardiology, and radiology. As hospitals strive to enhance operational efficiency and patient care through digital transformation, the demand for streamlined medical image management system has increased rapidly.

The Global Vendor Neutral Archive (VNA) Market is estimated to be valued at US$ 3.96 Bn in 2024 and is expected to exhibit a CAGR of 5.1% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the Global Vendor Neutral Archive (VNA) are Johnson & Johnson Private Limited, Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Baxter, Bayer AG, Eli Lilly and Company, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin , Allergan, AbbVie Inc., Abbott, Bausch Health Companies Inc. , Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, AstraZeneca.

Key opportunities in the market are rising adoption of cloud Global Vendor Neutral Archive (VNA) Market Trends and hybrid VNA models. Cloud VNA architecture is gaining prominence as it provides simplified data access, lower upfront installation costs and subscription-based pricing. Hybrid VNA combines the best of hosted and on-premises VNA solutions to address various requirements. Growing healthcare expenditures, establishment of imaging centers and expansion of insurance coverage in developing nations are also fueling market opportunities.

Global expansion in the market is supported by increasing R&D investments by major VNA players to develop advanced capabilities around interoperability, integrated workflows and artificial intelligence integration. International organizations are also supporting digital health transformation of hospitals through funding and initiatives. Developing Asian and Latin American markets have been witnessing faster penetration of VNA systems with improving healthcare infrastructure.

Market drivers include upsurge in demand for efficient medical image management owing to increasing volume of medical scans and images globally due to rising disease prevalence. The need for enhanced collaboration between radiologists, physicians, and other care teams further drives the adoption of centralized, interoperable VNA platforms. Regulatory emphasis on effective diagnostic decision making through timely imaging data access is another key factor fueling the Vendor Neutral Archive market growth.

Potential market restraints include budget constraints faced by smaller healthcare organizations for implementation of these capital intensive storage systems. Lack of skilled IT professionals and interoperability issues with legacy systems also act as a challenge for higher acceptance of Vendor Neutral Archive solutions. Data security and privacy risks associated with hosted VNA models require careful evaluation as well.

Segment Analysis

The global vendor neutral archive (VNA) market is fragmented on the basis of component, deployment mode, and application. The software segment is expected to be the dominating sub segment owing to the increasing demand for VNA software that provides a comprehensive clinical viewer for diagnostic images from multiple archiving systems as well as from standalone medical imaging equipment. The software provides flexibility in integration and management of image and data storage.

Global Analysis

Regionally, North America is expected to dominate the global vendor neutral archive market during the forecast period owing to rising healthcare expenditure and increasing adoption of imaging technologies and archiving solutions in this region. The Asia Pacific region is projected to witness the fastest growth over the forecast period due to increasing healthcare infrastructure, improving technologies access, and growing medical tourism industry in emerging economies of China and India. Furthermore, growing awareness regarding benefits of maintaining electronic healthcare records is also expected to boost the market growth in Asia Pacific region.

Get More Insights On- Global Vendor Neutral Archive (VNA) Market Trends

Comments

Post a Comment

Popular posts from this blog

Plasma Fractionation: The Process of Separating Blood Plasma into Useful Components

Image
  Plasma Fractionation What is Plasma Fractionation? Plasma fraction is the process of separating the different components of blood plasma through various physico-chemical processes like molecular size filtration, precipitation, chromatography and crystallization. Blood plasma, the liquid part of blood, contains thousands of proteins, antibodies, clotting factors and other components which help maintain homeostasis in the body. Plasma Fraction enables isolation of specific plasma proteins on a large scale which are then used to manufacture life-saving plasma derived medicines, diagnostics and medical therapies. Methods used in Plasma Fractionation Several specialized techniques are employed for separating the individual components from pooled donor plasma with high precision and purity. These include: - Cryoprecipitation: Based on temperature-dependent solubility, this involves cooling plasma gradually until certain proteins like Plasma Fractionation precipitate out. The su...
Read more

Theranostics: Transforming the Landscape of Personalized Medicine Innovative Approaches and Groundbreaking Advancements

Image
  Theranostics What is Theranostics? Theragnostics refers to an emerging field in medicine that combines therapeutic and diagnostic capabilities into single agents or platforms. The goal of theragnostics is to provide personalized patient care by selecting appropriate targeted therapies and monitoring their effectiveness. This novel approach has the potential to significantly improve treatment outcomes for many illnesses by matching therapies to individual molecular profiles. Theranostic Agents and Theranostics Theranostics relies on the development of agents and technologies that can both detect specific molecular abnormalities and targets within the body as well as deliver targeted therapies to those same areas. Some examples of theranostic platforms currently under investigation include: - Theranostic Nanoparticles: Nanoparticles are being engineered to incorporate both diagnostic imaging agents like fluorophores as well as targeted drug payloads. These "smart particles...
Read more

Mometasone Furoate Market is Anticipated to Witness High Growth Owing to Growing Prevalence of Allergic Diseases

Image
Mometasone Furoate Market Size Mometasone furoate is a synthetic corticosteroid applied topically to treat conditions such as eczema, psoriasis and dermatitis. It works by reducing inflammation and itching of the skin. It comes as a cream or ointment applied to the skin. Mometasone furoate products are used to treat flare-ups and reduce symptoms of allergic skin conditions. Growing prevalence of allergic diseases such as asthma, allergic rhinitis and atopic dermatitis across the world has increased the demand for anti-allergic medications including mometasone furoate products. The Global mometasone furoate market is estimated to be valued at US$ 1467.01 Bn in 2024 and is expected to exhibit a CAGR of 22.% over the forecast period 2024 To 2031. Key Takeaways Key players operating in the mometasone furoate market are Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Lonza Group, Miltenyi Biotec, Takara Bio Group, CellGenix GmbH, FUJIFILM Irvine Scientific, Agilent Technol...
Read more